• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和验证低级别神经胶质瘤中六个长链非编码 RNA 预后标志物及其 ceRNA 网络和候选药物。

Identification and validation of a six-lncRNA prognostic signature with its ceRNA networks and candidate drugs in lower-grade gliomas.

机构信息

Neurosurgical Department, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China.

Obstetrics & Gynecology Department, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China.

出版信息

Genomics. 2020 Sep;112(5):2990-3002. doi: 10.1016/j.ygeno.2020.05.016. Epub 2020 May 21.

DOI:10.1016/j.ygeno.2020.05.016
PMID:32447005
Abstract

Gliomas account for 75% of the primary malignant brain tumors and a majority of lower-grade gliomas (LGG) inevitably develop into glioblastoma. The dysregulation of lncRNAs play a crucial role in LGG. In the present study, we first screened out six differentially expressed lncRNAs (AC021739.2, AL031722.1, AL354740.1, FGD5-AS1, LINC00844, and NEAT1) based on TCGA and GTEx RNA-seq databases. LncRNA prognostic signature was then established by Kaplan-Meier and multivariate Cox proportional hazards regression, with its predictive value validated by time-dependent receiver operating characteristic (ROC) curves. After lncRNA-miRNA-mRNA regulatory networks were established by Cytoscape 3.7.2, Gene Oncology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed, with results enriched in various malignancy-related functions and pathways. Finally, six putative drugs (irinotecan, camptothecin, mitoxantrone, azacitidine, mestranol, and enilconazole) were predicted by Connectivity Map. In conclusion, we identified a 6-lncRNA prognostic signature with its ceRNA networks, and six candidate drugs against LGG.

摘要

神经胶质瘤占原发性脑恶性肿瘤的 75%,大多数低级别神经胶质瘤(LGG)不可避免地会发展成胶质母细胞瘤。lncRNAs 的失调在 LGG 中起着至关重要的作用。在本研究中,我们首先基于 TCGA 和 GTEx RNA-seq 数据库筛选出六个差异表达的 lncRNA(AC021739.2、AL031722.1、AL354740.1、FGD5-AS1、LINC00844 和 NEAT1)。然后通过 Kaplan-Meier 和多变量 Cox 比例风险回归建立 lncRNA 预后特征,并通过时间依赖性接收器操作特征(ROC)曲线验证其预测价值。通过 Cytoscape 3.7.2 建立 lncRNA-miRNA-mRNA 调控网络后,进行基因肿瘤学(GO)和京都基因与基因组百科全书(KEGG)分析,结果富集于各种恶性相关功能和途径。最后,通过连接图谱预测了六种潜在药物(伊立替康、喜树碱、米托蒽醌、阿扎胞苷、雌三醇和烯菌灵)。总之,我们确定了一个具有 ceRNA 网络的 6-lncRNA 预后特征和六种针对 LGG 的候选药物。

相似文献

1
Identification and validation of a six-lncRNA prognostic signature with its ceRNA networks and candidate drugs in lower-grade gliomas.鉴定和验证低级别神经胶质瘤中六个长链非编码 RNA 预后标志物及其 ceRNA 网络和候选药物。
Genomics. 2020 Sep;112(5):2990-3002. doi: 10.1016/j.ygeno.2020.05.016. Epub 2020 May 21.
2
Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.鉴定和验证一种新型的八个突变衍生的长非编码 RNA 特征作为低级别胶质瘤基因组不稳定性的预后生物标志物。
Aging (Albany NY). 2021 Jun 3;13(11):15164-15192. doi: 10.18632/aging.203079.
3
Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.鉴定Glioma 中上皮-间充质转化相关的长非编码 RNA(LncRNA)特征。
Bioengineered. 2021 Dec;12(1):4016-4031. doi: 10.1080/21655979.2021.1951927.
4
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.预测低级别胶质瘤预后的免疫相关标志物。
Front Immunol. 2020 Dec 8;11:603341. doi: 10.3389/fimmu.2020.603341. eCollection 2020.
5
Identification and validation of a five-lncRNA signature for predicting survival with targeted drug candidates in ovarian cancer.鉴定和验证五个 lncRNA 标志物,用于预测卵巢癌靶向候选药物治疗的生存情况。
Bioengineered. 2021 Dec;12(1):3263-3274. doi: 10.1080/21655979.2021.1946632.
6
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.系统分析 lncRNA-miRNA-mRNA 竞争内源性 RNA 网络鉴定出四个 lncRNA 特征作为乳腺癌的预后生物标志物。
J Transl Med. 2018 Sep 27;16(1):264. doi: 10.1186/s12967-018-1640-2.
7
Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.鉴定和验证与低级别胶质瘤相关的能量代谢 lncRNA-mRNA 特征。
Biomed Res Int. 2020 Jul 27;2020:3708231. doi: 10.1155/2020/3708231. eCollection 2020.
8
Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.基于生物信息学分析鉴定和验证与Glioma 相关的五个长链非编码 RNA 预后标志物。
BMC Cancer. 2021 Mar 9;21(1):251. doi: 10.1186/s12885-021-07972-9.
9
Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.基于九个免疫相关长链非编码RNA的低级别胶质瘤个体化预后标志物的鉴定与验证
Clin Neurol Neurosurg. 2021 Feb;201:106464. doi: 10.1016/j.clineuro.2020.106464. Epub 2021 Jan 5.
10
A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.弥漫性低级别胶质瘤患者个体化预后评估和放疗指导的五个 miRNA 特征。
J Cell Mol Med. 2020 Jul;24(13):7504-7514. doi: 10.1111/jcmm.15377. Epub 2020 May 15.

引用本文的文献

1
Comprehensive analysis of disulfidptosis-related lncRNAs for predicting prognosis and response of immunotherapy in pancreatic adenocarcinoma.用于预测胰腺腺癌预后及免疫治疗反应的二硫化物化坏死相关长链非编码RNA的综合分析
Transl Cancer Res. 2024 Mar 31;13(3):1336-1350. doi: 10.21037/tcr-23-1706. Epub 2024 Mar 27.
2
Identification of RP11-770J1.4 as immune-related lncRNA regulating the CTXN1-cGAS-STING axis in histologically lower-grade glioma.鉴定RP11-770J1.4为免疫相关长链非编码RNA,其在组织学低级别胶质瘤中调控CTXN1-cGAS-STING轴。
MedComm (2020). 2023 Dec 19;4(6):e458. doi: 10.1002/mco2.458. eCollection 2023 Dec.
3
Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets.
长链非编码RNA和微小RNA在胶质瘤进展中的作用及其作为新型治疗靶点的潜力的见解
Cancers (Basel). 2023 Jun 22;15(13):3298. doi: 10.3390/cancers15133298.
4
LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.LINC00844 通过抑制胆管癌中的 miR-19a-5p 抑制肿瘤进展并预测生存结局。
Clin Transl Oncol. 2024 Feb;26(2):414-423. doi: 10.1007/s12094-023-03254-x. Epub 2023 Jul 3.
5
FXR1 promotes glioma progression by downregulating microRNA-124-3p through long noncoding RNA FGD5-AS1 upregulation.FXR1 通过上调长链非编码 RNA FGD5-AS1 下调 microRNA-124-3p 促进胶质瘤进展。
Acta Neurol Belg. 2023 Aug;123(4):1453-1464. doi: 10.1007/s13760-023-02263-5. Epub 2023 Apr 19.
6
Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma.低级别胶质瘤中焦亡相关RNA模式的预后及免疫特征
Front Oncol. 2022 Dec 20;12:1015850. doi: 10.3389/fonc.2022.1015850. eCollection 2022.
7
Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation.预测肾透明细胞癌预后的染色质调节因子相关lncRNA特征及其与免疫微环境的关系:一项基于生物信息学和实验验证的研究
Front Genet. 2022 Oct 20;13:974726. doi: 10.3389/fgene.2022.974726. eCollection 2022.
8
A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma.一种用于胶质瘤预后预测和免疫治疗的新型内质网应激相关lncRNA特征
Front Oncol. 2022 Jun 30;12:930923. doi: 10.3389/fonc.2022.930923. eCollection 2022.
9
Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis.与基因组不稳定相关的长链非编码RNA揭示了胶质瘤免疫治疗和预后的生物标志物。
Front Genet. 2022 Apr 27;13:850888. doi: 10.3389/fgene.2022.850888. eCollection 2022.
10
The role of long non-coding RNA FGD5-AS1 in cancer.长链非编码 RNA FGD5-AS1 在癌症中的作用。
Bioengineered. 2022 Apr;13(4):11026-11041. doi: 10.1080/21655979.2022.2067292.